CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Takeda Pharmaceutical Company Limited - 4502 CFD

4208.88
1.25%
Market Trading Hours* (UTC) Opens on Tuesday at 00:00

Tue - Fri: 00:00 - 02:30 03:30 - 06:25

  • Summary
  • Historical Data
Trading сonditions
Spread 10.24
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.012355 %
Charges from full value of position ($-2.35)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.012355%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.009867 %
Charges from full value of position ($-1.87)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.009867%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 4156.83
Open 4207.18
1-Year Change -5.5%
Day's Range 4189.8 - 4217.07
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 4208.88 16.98 0.41% 4191.90 4219.07 4187.80
Feb 20, 2025 4156.83 -0.10 -0.00% 4156.93 4169.22 4127.86
Feb 19, 2025 4182.91 -33.96 -0.81% 4216.87 4243.25 4171.82
Feb 18, 2025 4224.27 42.56 1.02% 4181.71 4244.35 4181.71
Feb 17, 2025 4202.79 70.93 1.72% 4131.86 4229.36 4127.86
Feb 14, 2025 4145.14 -36.37 -0.87% 4181.51 4198.89 4134.16
Feb 13, 2025 4176.91 45.95 1.11% 4130.96 4186.90 4129.86
Feb 12, 2025 4066.02 -19.98 -0.49% 4086.00 4104.98 4059.93
Feb 10, 2025 4106.68 -21.28 -0.52% 4127.96 4131.96 4094.89
Feb 7, 2025 4131.16 1.50 0.04% 4129.66 4140.45 4105.88
Feb 6, 2025 4155.14 33.17 0.80% 4121.97 4164.13 4116.86
Feb 5, 2025 4087.90 -19.08 -0.46% 4106.98 4115.27 4069.92
Feb 4, 2025 4124.97 -13.78 -0.33% 4138.75 4147.94 4099.89
Feb 3, 2025 4115.97 -22.98 -0.56% 4138.95 4151.44 4086.90
Jan 31, 2025 4214.77 -31.07 -0.73% 4245.84 4261.03 4190.90
Jan 30, 2025 4171.92 -5.09 -0.12% 4177.01 4190.20 4145.84
Jan 29, 2025 4138.95 11.89 0.29% 4127.06 4161.53 4120.87
Jan 28, 2025 4161.13 46.76 1.14% 4114.37 4162.83 4094.89
Jan 27, 2025 4088.00 30.87 0.76% 4057.13 4114.58 4057.13
Jan 24, 2025 4035.06 -8.99 -0.22% 4044.05 4071.32 4024.96

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Takeda Pharmaceutical Company Limited Company profile

About Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Takeda Pharmaceutical Co Ltd revenues increased 11% to Y2.696T. Net income applicable to common stockholders increased 35% to Y241.42B. Revenues reflect Intellectual Property And Service Revenue segment increase from Y69.04B to Y210.55B, Pharmaceutical Business segment increase of 5% to Y2.485T, Northern America segment increase of 9% to Y1.297T, Japan segment increase of 22% to Y530.25B.

Equity composition

FY'94-02 WAS were estimated. FY'04 Name changed from Takeda Chemical Industries, Ltd. to Takeda Pharmaceutical Company Limited. All 1&3Q, WAS were estimated and used as O/S. FY'08 Q3 WAS=O/S. FY'11 Q3 DWAS is estimated.

Industry: Pharmaceuticals (NEC)

4階
日本橋本町二丁目1番1号
CHUO-KU
TOKYO-TO 103-8668
JP

People also watch

ETH/USD

2,779.27 Price
+5.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,674.75 Price
+1.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading